Janney Montgomery Scott’s VanEck Biotech ETF BBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $572K | Buy |
3,040
+100
| +3% | +$19.3K | ﹤0.01% | 1962 |
|
|
2025
Q4 | $556K | Hold |
2,940
| – | – | ﹤0.01% | 2120 |
|
|
2025
Q3 | $487K | Sell |
2,940
-125
| -4% | -$20.4K | ﹤0.01% | 2160 |
|
|
2025
Q2 | $470K | Hold |
3,065
| – | – | ﹤0.01% | 2052 |
|
|
2025
Q1 | $482K | Hold |
3,065
| – | – | ﹤0.01% | 2011 |
|
|
2024
Q4 | $481K | Buy |
+3,065
| New | +$516K | ﹤0.01% | 2027 |
|
|
2024
Q3 | – | Sell |
-3,165
| Closed | -$533K | – | 2667 |
|
|
2024
Q2 | $533K | Sell |
3,165
-1,100
| -26% | -$180K | ﹤0.01% | 1837 |
|
|
2024
Q1 | $709K | Sell |
4,265
-150
| -3% | -$24.8K | ﹤0.01% | 1719 |
|
|
2023
Q4 | $730K | Sell |
4,415
-1,470
| -25% | -$226K | ﹤0.01% | 1643 |
|
|
2023
Q3 | $916K | Sell |
5,885
-451
| -7% | -$72K | ﹤0.01% | 1389 |
|
|
2023
Q2 | $989K | Buy |
6,336
+51
| +0.8% | +$8.15K | ﹤0.01% | 1418 |
|
|
2023
Q1 | $1.02M | Sell |
6,285
-235
| -4% | -$38K | ﹤0.01% | 1303 |
|
|
2022
Q4 | $1.04M | Sell |
6,520
-1,050
| -14% | -$166K | ﹤0.01% | 1350 |
|
|
2022
Q3 | $1.07M | Sell |
7,570
-650
| -8% | -$98.3K | ﹤0.01% | 1270 |
|
|
2022
Q2 | $1.2M | Sell |
8,220
-2,659
| -24% | -$396K | 0.01% | 1153 |
|
|
2022
Q1 | $1.76M | Sell |
10,879
-1,100
| -9% | -$178K | 0.01% | 970 |
|
|
2021
Q4 | $2.27M | Buy |
11,979
+3,200
| +36% | +$617K | 0.01% | 917 |
|
|
2021
Q3 | $1.77M | Sell |
8,779
-12
| -0.1% | -$2.52K | 0.01% | 1007 |
|
|
2021
Q2 | $1.77M | Hold |
8,791
| – | – | 0.01% | 993 |
|
|
2021
Q1 | $1.54M | Buy |
8,791
+125
| +1% | +$22.6K | 0.01% | 1002 |
|
|
2020
Q4 | $1.47M | Buy |
8,666
+1,471
| +20% | +$242K | 0.01% | 995 |
|
|
2020
Q3 | $1.17M | Buy |
7,195
+1,000
| +16% | +$163K | 0.01% | 1028 |
|
|
2020
Q2 | $1.01M | Buy |
6,195
+100
| +2% | +$15.2K | 0.01% | 1034 |
|
|
2020
Q1 | $780K | Hold |
6,095
| – | – | 0.01% | 1033 |
|
|
2019
Q4 | $850K | Hold |
6,095
| – | – | 0.01% | 1163 |
|
|
2019
Q3 | $719K | Buy |
6,095
+100
| +2% | +$12.4K | 0.01% | 1185 |
|
|
2019
Q2 | $773K | Hold |
5,995
| – | – | 0.01% | 1179 |
|
|
2019
Q1 | $770K | Sell |
5,995
-200
| -3% | -$25.3K | 0.01% | 1161 |
|
|
2018
Q4 | $686K | Buy |
6,195
+200
| +3% | +$24.2K | 0.01% | 1120 |
|
|
2018
Q3 | $816K | Hold |
5,995
| – | – | 0.01% | 1159 |
|
|
2018
Q2 | $719K | Buy |
5,995
+150
| +3% | +$17.7K | 0.01% | 1177 |
|
|
2018
Q1 | $703K | Sell |
5,845
-525
| -8% | -$65.9K | 0.01% | 1135 |
|
|
2017
Q4 | $794K | Sell |
6,370
-850
| -12% | -$109K | 0.01% | 1060 |
|
|
2017
Q3 | $968K | Sell |
7,220
-1,025
| -12% | -$133K | 0.01% | 948 |
|
|
2017
Q2 | $1.04M | Sell |
8,245
-380
| -4% | -$45.8K | 0.01% | 856 |
|
|
2017
Q1 | $1.03M | Hold |
8,625
| – | – | 0.01% | 827 |
|
|
2016
Q4 | $928K | Buy |
+8,625
| New | +$938K | 0.01% | 802 |
|
Other funds holding BBH
MIM
CCA
BFG
Janney Montgomery Scott's BBH Position: Q1 2026 in Review
Janney Montgomery Scott increased its VanEck Biotech ETF (BBH) stake by 3.4% in Q1 2026, buying an estimated $19.3K and bringing the position to 3,040 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #1962.
Janney Montgomery Scott first reported a position in BBH in Q4 2016 and has held it in 37 quarters since. The position peaked at $2.27M in Q4 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.
- Janney Montgomery Scott held 3,040 shares of VanEck Biotech ETF worth $572K as of Q1 2026.
- Janney Montgomery Scott bought 100 VanEck Biotech ETF shares in Q1 2026, an estimated $19.3K.
- VanEck Biotech ETF made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q1 2026, its #1962 holding.
- Janney Montgomery Scott first reported a position in VanEck Biotech ETF in Q4 2016 and has held it in 37 quarters since.
- Janney Montgomery Scott's VanEck Biotech ETF position peaked at $2.27M in Q4 2021.
- 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.
Based on Janney Montgomery Scott's 13F filing for Q1 2026, filed 22 Apr 2026.